Search results
For Black Women, Accessing Weight-Loss Drugs Is a Difficult Journey
PopSugar· 17 hours agoFor many Black women facing or in the obesity index, it can often feel like there's no way out when...
Weight loss jabs not a quick fix to get beach-body ready, warns top NHS doc
Daily Express· 13 hours agoPowerful weight loss jabs are not “a quick fix for people trying to get ‘beach body ready’” this...
FDA approves AstraZeneca’s Farxiga for paediatric T2D patients
Pharmaceutical Technology via Yahoo Finance· 23 hours agoThe US Food and Drug Administration (FDA) has granted approval for AstraZeneca's Farxiga...
Tampa Bay residents among those alleging Ozempic caused stomach paralysis
Tampa Bay Times· 17 hours agoTony Thompson thought he was taking a type of insulin when he was prescribed Ozempic to treat his ...
NHS offers free diabetes checks in Wolverhampton
BBC News· 2 days agoFree health checks to assess people's risk of diabetes will be offered in Wolverhampton. The service will be held in a mobile testing bus at various...
Wait—Why Am I Not Losing Weight on Ozempic?
Parade via Yahoo News· 4 days agoHowever, its side effects, like "Ozempic face," "Ozempic butt" and GI discomfort, have been discussed often on social media and even a primetime Oprah...
Abbott Wins FDA Approval For Two Over-The-Counter Diabetes Trackers
Forbes· 4 days agoAbbott Laboratories Monday said the U.S. Food and Drug Administration has cleared for sale two new...
Is Eli Lilly Stock A Buy After FDA Advisors Back Its Alzheimer's Drug?
Investor's Business Daily· 3 days agoShares of companies working on treatments for metabolic dysfunction-associated steatohepatitis, or...
Bernie Sanders Wants to Subpoena Novo Nordisk Over Wegovy’s Price. What to Know.
Barrons.com· 2 days agoOzempic, the brand name under which the same medicine is sold as a Type 2 diabetes treatment, has a...
Jim Cramer says Eli Lilly isn't a ‘one trick pony' after FDA advisers endorse its Alzheimer's drug
NBC San Diego· 2 days agoContinually confident about Eli Lilly because of the enormous success of its weight loss and diabetes drugs, CNBC's Jim Cramer said the company's new Alzheimer's treatment ...
